NM_006231.4:c.755C>T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_006231.4(POLE):c.755C>T(p.Ala252Val) variant causes a missense change. The variant allele was found at a frequency of 0.0991 in 1,613,392 control chromosomes in the GnomAD database, including 8,666 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_006231.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0770 AC: 11705AN: 152046Hom.: 602 Cov.: 32
GnomAD3 exomes AF: 0.0860 AC: 21621AN: 251472Hom.: 1088 AF XY: 0.0872 AC XY: 11852AN XY: 135912
GnomAD4 exome AF: 0.101 AC: 148220AN: 1461228Hom.: 8064 Cov.: 32 AF XY: 0.100 AC XY: 72931AN XY: 726958
GnomAD4 genome AF: 0.0769 AC: 11700AN: 152164Hom.: 602 Cov.: 32 AF XY: 0.0760 AC XY: 5650AN XY: 74380
ClinVar
Submissions by phenotype
not specified Benign:4
- -
- -
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
- -
not provided Benign:3
- -
Variant summary: The POLE c.755C>T (p.Ala252Val) variant involves the alteration of a conserved nucleotide. 3/4 in silico tools predict a benign outcome (Mutation Taster not captured due to low p-value). This variant was found in 10401/121392 control chromosomes (545 homozygotes) at a frequency of 0.0856811, which is 6032 times the estimated maximal expected allele frequency of a pathogenic POLE variant (0.0000142), highly suggesting this variant is a benign polymorphism. The variant has been identified in patients, but not at a significantly higher frequency than in healthy controls (Kane_Cancer Res_2014). Taken together, this variant is classified as benign. -
- -
Colorectal cancer, susceptibility to, 12 Benign:1
- -
Hereditary cancer-predisposing syndrome Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at